Simplify Logo

Internship

2025 Co-op

Delivery Science-Analytical Research

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Healthcare
Biotechnology

Cambridge, MA, USA

Co-op opportunity in Cambridge, MA from January 21, 2025 – June 20, 2025.

Category
Bioinformatics
Biology Lab & Research
Biology & Biotech
Requirements
  • Current Junior or Senior student enrolled in a bachelor program in Chemistry, Chemical Engineering, Biochemical Engineering, Biomedical Engineering, or a related field
  • Experience working in a lab; knowledge of general chemical safety protocols
  • Fundamental knowledge of analytical techniques and lab procedures.
Responsibilities
  • Perform experiments using various analytical techniques, such as chromatography, spectroscopy, and mass spectrometry
  • Support the development and validation of analytical methods
  • Support the formulation of LNPs
  • Analyze and interpret experimental data, and communicate research findings across departments
  • Maintain good documentation practice and detailed scientific records of experiments
  • Collaborate with cross-functional teams on the research projects
  • Maintain and troubleshoot laboratory instruments

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

8%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.